Q2 2024 Holdings
Filed 2024-08-14 | 85 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $109.0M | 245,000 | 4.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $90.1M | 1,170,100 | 3.8% |
| Natera Inc(NTRA) | COM | 632307104 | $83.0M | 766,500 | 3.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $79.5M | 2,987,845 | 3.4% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $75.6M | 1,120,000 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $75.5M | 2,917,231 | 3.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $68.5M | 3,335,000 | 2.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $67.6M | 491,000 | 2.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $65.4M | 3,086,000 | 2.8% |
| The Cigna Group(CI) | COM | 125523100 | $61.0M | 184,500 | 2.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $58.1M | 544,500 | 2.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $53.9M | 222,000 | 2.3% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $50.4M | 48,000 | 2.1% |
| Illumina Inc(ILMN) | COM | 452327109 | $49.9M | 478,000 | 2.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $49.5M | 372,000 | 2.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $47.6M | 277,800 | 2.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $44.2M | 80,000 | 1.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $42.2M | 1,075,000 | 1.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $41.3M | 383,000 | 1.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $40.9M | 1,296,225 | 1.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $40.2M | 325,000 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $39.5M | 960,000 | 1.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $39.2M | 1,117,000 | 1.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $37.5M | 150,000 | 1.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $35.2M | 840,219 | 1.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $35.0M | 110,000 | 1.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $32.1M | 529,000 | 1.4% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $31.1M | 1,306,477 | 1.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $30.3M | 3,037,668 | 1.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $30.3M | 376,000 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.4M | 754,000 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $29.4M | 259,000 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $29.3M | 755,000 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $28.8M | 430,000 | 1.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $27.4M | 400,000 | 1.2% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $27.2M | 1,559,826 | 1.2% |
| Glaukos Corp(GKOS) | COM | 377322102 | $26.5M | 224,000 | 1.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $26.5M | 727,537 | 1.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $26.0M | 60,500 | 1.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $25.0M | 731,104 | 1.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $24.1M | 531,000 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $24.0M | 908,000 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.7M | 1,100,000 | 1.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $23.3M | 290,000 | 1.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $21.4M | 284,000 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $19.2M | 487,000 | 0.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $17.8M | 782,000 | 0.8% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $17.7M | 1,800,000 | 0.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $17.6M | 398,000 | 0.7% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $17.5M | 255,000 | 0.7% |